Pharmaceutical Industry Information Portal

HomeNews

News

SHINE and ImaginAb sign clinical supply agreement for lutetium-177 to drive innovation in cancer treatment

SHINE Technologies, a next-generation nuclear technology company, and ImaginAb Inc., a market-leading global biotechnology company focused on developing next-generation immuno-oncology imaging agents and therapeutic...

New investigational immunotherapy method for the treatment of patients with glioblastoma

Sharp HealthCare is a not-for-profit regional health care group, in collaboration with Nascent Biotech, Inc, a company pioneering the development of monoclonal antibodies, announced...

Moderna plans to expand its portfolio of global public health vaccines to 15 total programs

Moderna announces commitment to advance vaccines targeting 15 pathogens identified as biggest public health risk by WHO and CEPI into clinical studies by 2025 Moderna...

Lawmakers in the U.S. push for a permanent ban on illicit versions of fentanyl

A bipartisan trio of U.S. Congressmen on Monday unveiled new legislation that would permanently ban illicit versions of fentanyl, the powerful synthetic painkiller that...

Novartis and Voyager Therapeutics announce partnership to develop next-generation gene therapy for neurological diseases

Novartis today announced a license option agreement with Voyager Therapeutics, a gene therapy company focused on next-generation adeno-associated virus (AAV) technologies, for three capsids...

Moderna will establish mRNA vaccine manufacturing facility in Kenya

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that with the assistance of the U.S. Government, it has...
spot_img

Expert Articles

spot_img